CMPX
Compass Therapeutics Inc.
NASDAQ: CMPX · HEALTHCARE · BIOTECHNOLOGY
$1.67
-9.24% today
Updated 2026-04-29
Market cap
$300.75M
P/E ratio
—
P/S ratio
269.28x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$2 – $7
Volume
6.7M
Compass Therapeutics Inc. (CMPX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-33.68M | $-31.74M | $-26.80M | $-19.67M | $-34.13M | $-40.62M | $-44.85M | $-49.14M |
| Capital expenditures | $2.02M | $466000.00 | $106000.00 | $1.57M | $212000.00 | $30000.00 | $44000.00 | $25000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $656000.00 | $915000.00 | $4.02M | $4.03M | $5.33M | $6.12M | $8.56M | $8.37M |
| Free cash flow | $-35.70M | $-32.21M | $-26.91M | $-21.23M | $-34.34M | $-40.65M | $-44.90M | $-49.17M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $21.77M | $97.17M | $-109.57M | — | — | — |